Athwal H, Kochiyanil A, Bhat V, Allan A, Parsyan A
    
    
    Front Oncol. 2024; 14:1370565.
  
  
    PMID: 38606093
    
          PMC: 11007099.
    
          DOI: 10.3389/fonc.2024.1370565.
      
 
                                  
  
    Li Q, Kaur A, Okada K, McKenney R, Engebrecht J
    
    
    PLoS Genet. 2023; 19(1):e1010457.
  
  
    PMID: 36716349
    
          PMC: 9910797.
    
          DOI: 10.1371/journal.pgen.1010457.
      
 
                                  
  
    Haynes B, Cunningham K, Shekhar M
    
    
    BMC Cancer. 2022; 22(1):1073.
  
  
    PMID: 36258187
    
          PMC: 9578210.
    
          DOI: 10.1186/s12885-022-10119-z.
      
 
                                  
  
    Jia Z, Wang X, Zhang H
    
    
    Cancer Drug Resist. 2022; 2(2):210-224.
  
  
    PMID: 35582716
    
          PMC: 8992632.
    
          DOI: 10.20517/cdr.2018.010.
      
 
                                  
  
    Witus S, Stewart M, Klevit R
    
    
    Biochem J. 2021; 478(18):3467-3483.
  
  
    PMID: 34591954
    
          PMC: 8763022.
    
          DOI: 10.1042/BCJ20200864.
      
 
                              
              
                              
                                      
  Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand.
  
    Patel P, Algouneh A, Hakem R
    
    
    Oncogene. 2021; 40(17):3001-3014.
  
  
    PMID: 33716297
    
    
          DOI: 10.1038/s41388-021-01744-2.
      
 
                                          
                                                          
  Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
  
    Yoshida R
    
    
    Breast Cancer. 2020; 28(6):1167-1180.
  
  
    PMID: 32862296
    
          PMC: 8514387.
    
          DOI: 10.1007/s12282-020-01148-2.
      
 
                                          
                                                          
  Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors.
  
    Somma M, Andreyeva E, Pavlova G, Pellacani C, Bucciarelli E, Popova J
    
    
    Cells. 2020; 9(6).
  
  
    PMID: 32604778
    
          PMC: 7348712.
    
          DOI: 10.3390/cells9061554.
      
 
                                          
                                                          
  The tumor suppressor BRCA1-BARD1 complex localizes to the synaptonemal complex and regulates recombination under meiotic dysfunction in Caenorhabditis elegans.
  
    Li Q, Saito T, Martinez-Garcia M, Deshong A, Nadarajan S, Lawrence K
    
    
    PLoS Genet. 2018; 14(11):e1007701.
  
  
    PMID: 30383767
    
          PMC: 6211623.
    
          DOI: 10.1371/journal.pgen.1007701.
      
 
                                          
                                                          
  FANCJ at the FORK.
  
    Cantor S, Nayak S
    
    
    Mutat Res. 2016; 788:7-11.
  
  
    PMID: 26926912
    
          PMC: 4887407.
    
          DOI: 10.1016/j.mrfmmm.2016.02.003.
      
 
                                          
                                                          
  CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.
  
    Ertych N, Stolz A, Valerius O, Braus G, Bastians H
    
    
    Proc Natl Acad Sci U S A. 2016; 113(7):1817-22.
  
  
    PMID: 26831064
    
          PMC: 4763769.
    
          DOI: 10.1073/pnas.1525129113.
      
 
                                          
                                                          
  Centrosomes and cancer: revisiting a long-standing relationship.
  
    Gonczy P
    
    
    Nat Rev Cancer. 2015; 15(11):639-52.
  
  
    PMID: 26493645
    
    
          DOI: 10.1038/nrc3995.
      
 
                                          
                                                          
  The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability.
  
    Luddecke S, Ertych N, Stenzinger A, Weichert W, Beissbarth T, Dyczkowski J
    
    
    Oncogene. 2015; 35(18):2398-406.
  
  
    PMID: 26300001
    
    
          DOI: 10.1038/onc.2015.290.
      
 
                                          
                                                          
  Centrosome/Cell cycle uncoupling and elimination in the endoreduplicating intestinal cells of C. elegans.
  
    Lu Y, Roy R
    
    
    PLoS One. 2014; 9(10):e110958.
  
  
    PMID: 25360893
    
          PMC: 4215990.
    
          DOI: 10.1371/journal.pone.0110958.
      
 
                                          
                                                          
  Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.
  
    Sternemalm J, Russnes H, Zhao X, Risberg B, Nord S, Caldas C
    
    
    Br J Cancer. 2014; 111(2):326-38.
  
  
    PMID: 24901235
    
          PMC: 4102947.
    
          DOI: 10.1038/bjc.2014.297.
      
 
                                          
                                                          
  DNA-PKcs activates the Chk2-Brca1 pathway during mitosis to ensure chromosomal stability.
  
    Shang Z, Yu L, Lin Y, Matsunaga S, Shen C, Chen B
    
    
    Oncogenesis. 2014; 3:e85.
  
  
    PMID: 24492479
    
          PMC: 3940919.
    
          DOI: 10.1038/oncsis.2013.49.
      
 
                                          
                                                          
  OLA1 in centrosome biology alongside the BRCA1/BARD1 complex: looking beyond centrosomes.
  
    Gomez V, Hergovich A
    
    
    Mol Cell. 2014; 53(1):3-5.
  
  
    PMID: 24411079
    
          PMC: 3926090.
    
          DOI: 10.1016/j.molcel.2013.12.016.
      
 
                                          
                                                          
  FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.
  
    Zou J, Tian F, Li J, Pickner W, Long M, Rezvani K
    
    
    Biol Open. 2013; 2(10):1022-31.
  
  
    PMID: 24167712
    
          PMC: 3798185.
    
          DOI: 10.1242/bio.20135801.
      
 
                                          
                                                          
  Functional differences among BRCA1 missense mutations in the control of centrosome duplication.
  
    Kais Z, Chiba N, Ishioka C, Parvin J
    
    
    Oncogene. 2011; 31(6):799-804.
  
  
    PMID: 21725363
    
          PMC: 4222025.
    
          DOI: 10.1038/onc.2011.271.